Physicians’ agreement with evidence-based guidelines for polycystic ovary syndrome management: implications for future policy and practice
Abstract
Background Polycystic ovary syndrome(PCOS) is a frequently prevalent health issue that significantly affects women’s reproductive health. The prompt diagnosis and suitable treatment methods employed by medical professionals determine favorable clinical outcomes of the disease.
Objective The present study aimed to explore physicians’ agreement with the standard guidelines for PCOS diagnosis and treatment.
Methods The cross-sectional study was conducted using a selfadministered 36-item questionnaire at four public and three private tertiary care hospitals and different clinics in Karachi, Pakistan.
Results The overall response rate of the present study was 77.3%, with a mean age of 36.1±11.9 years. The Rotterdam criteria were the most commonly used measure for the diagnosis of PCOS by (n=112, 71.3%) respondents; however, the response rate varied significantly with their experience (p<0.001). Lifestyle modifications (n=149, 94.9%) and metformin (n=142, 90.4%) were the treatments most commonly prescribed by the respondents. Almost all the respondents (n=150, 95.5%) consider obesity, infertility, and hirsutism when prescribing hormonal medications for PCOS.
Conclusions The outcomes revealed a disparity in the diagnostic approaches of PCOS among the respondents. The findings can be used to establish strategies to raise knowledge among primary care physicians, shorten the time it takes to diagnose cases, and, ultimately, better manage women who have the condition.
Bangladesh…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 150 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.